Navigation Links
New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C)

ion can significantly interfere with daily activities and reduce patients' quality of life, resulting in absences from school, missed work and reduced productivity.

Three main types include IBS with constipation (IBS-C), with diarrhea (IBS-D) and with mixed symptoms of constipation and diarrhea (IBS-M). In IBS- C, symptoms are present for at least 3 days per month over a 3-month period. Although people with IBS-C report suffering from many of the same symptoms associated with constipation, the presence of abdominal discomfort and pain is what differentiates IBS-C from chronic constipation. Additionally, the hypersensitivity of the gastrointestinal system of individuals with IBS makes them more prone to experience the effects of even mild symptoms of constipation or diarrhea. The condition is approximately 2 to 2.5 times more prevalent in women than men, and women are more likely to report a history of constipation.

About AMITIZA(R) (lubiprostone) 24 mcg BID for Chronic Idiopathic Constipation

AMITIZA is indicated for the treatment of Chronic Idiopathic Constipation in the adult population. AMITIZA should not be used in patients with a known hypersensitivity to any components of the formulation and in patients with a history of mechanical gastrointestinal obstruction. Patients with symptoms suggestive of mechanical gastrointestinal obstruction should be evaluated prior to initiating AMITIZA treatment.

The safety of AMITIZA in pregnancy has not been evaluated in humans. In guinea pigs, lubiprostone has been shown to have the potential to cause fetal loss. AMITIZA should be used during pregnancy only if the benefit justifies the potential risk to the fetus. Women who could become pregnant should have a negative pregnancy test prior to beginning therapy with AMITIZA and should be capable of complying with effective contraceptive measures.

AMITIZA should not be administered to patients that have severe diarrhea. Patients should be aware
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:7/31/2015)... CHICAGO , July 31, 2015 ... a press release on July 28, 2015, "Surviving ... Safety Launches Fundraising for Patient Safety." ... last sentence should read: "PPAHS is ... of Patients on Opioids. For more information on the ...
(Date:7/31/2015)... , July 31, 2015 ... decades of experience, the domestic pharmaceutical industry is strong, ... manufacture products to high international standards. One ... known is in sub-Saharan Africa: Morocco has quietly become ... South Africa . Indeed, Moroccan pharma ...
(Date:7/31/2015)... MONROVIA, Calif. , July 31, 2015  Xencor, ... developing engineered monoclonal antibodies for the treatment of autoimmune ... the appointment of Yujiro S. Hata to ... of experience in business and corporate development is a ... , Ph.D., president and chief executive officer of Xencor. ...
Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... March 8, 2011 CardioGenics Holdings Inc. (OTC Bulletin Board: ... available to its common stockholders and Series 2 Class B ... assist it in obtaining an accurate share count of the ... brokers, banks or other nominees. If you ...
... 2011 Blue Horseshoe, a Carmel-headquartered software development and ... software solutions to Fortune 500 and mid-market businesses throughout ... its scope and using its extensive supply chain experience ... its newest division, Blue Horseshoe Intellectual Property (BHIP). ...
Cached Medicine Technology:CardioGenics Requests Stockholders to Participate in Stockholder Questionnaires 2Software Development Firm's New Intellectual Property Group, Blue Horseshoe IP Creates Solutions to Help Customers Optimize Supply Chain 2Software Development Firm's New Intellectual Property Group, Blue Horseshoe IP Creates Solutions to Help Customers Optimize Supply Chain 3
(Date:8/1/2015)... ... 02, 2015 , ... Back packs can be dangerous? Whaaat?! , Not the ... wreck havoc on a kid's spine. With school starting again, most kids will be ... sure you are aware of how to help them prevent injuries by understanding backpack ...
(Date:8/1/2015)... ... August 01, 2015 , ... The condition where veins ... men and women often causing pain and discomfort. Those who spend a lot of ... and Northeast Houston Vein Center is doing what it can to create awareness and ...
(Date:8/1/2015)... ... August 01, 2015 , ... Brig and Lita Hart, icons of the ... of their Healthy Home mission with the HOPE Movement of EvolvHealth. In what has ... both companies have agreed to join their missions of purpose together to change the ...
(Date:8/1/2015)... ... ... Lume Wellness creators Alex, Robert, and Sam have announced update 3.0.1 to ... , The app is designed to track various metrics of wellness, including physical activity, ... health and use this information for positive behavior modification. Lume Wellness keeps track of ...
(Date:8/1/2015)... ... ... On March 19, 2015 Phil Valentine – the Executive Director of Connecticut Community for Addiction ... stepping off Springer Mountain and heading north. Since that day, Phil has hiked over 1400 ... greeted by friends and family. He visited CCAR and left an inspirational message to ...
Breaking Medicine News(10 mins):Health News:Local AlignLife Doctor Donates Time to Check Back Packs 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2
... ... ... ... ...
... ... ... , ... ...
... ... ... ... ...
... shown to be effective in breast cancer packs an effective ... a specific genetic mutation, a study at UCLA,s Jonsson Comprehensive ... when given together proved to significantly inhibit tumor growth in ... mutation that results in an aggressive form of the disease, ...
... scientists studying acute forms of Leukaemia have identified a new ... the growth of diseased cells. The research, reported in ... to genes, which if targeted could prevent diseased cells from ... the University of Vienna, carried out their research on acute ...
... bone mineral density, strength and postural balance due to ... group of women but also for elderly men, says ... and continues "It is well known that the risk ... result of weaker bones, poorer balance and attenuated ability ...
Cached Medicine News:Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 2Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 3Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 4Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 5Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 6Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 2Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 3Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 4Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 5Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 6Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 7Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 8Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 9Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 10Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 11Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 12Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 13Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 14Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 15Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 16Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 17Health News:Marketech Celebrates 25 Years of Service 2Health News:Marketech Celebrates 25 Years of Service 3Health News:Marketech Celebrates 25 Years of Service 4Health News:Marketech Celebrates 25 Years of Service 5Health News:Herceptin and Tykerb effective against a subset of gastric cancers 2Health News:Herceptin and Tykerb effective against a subset of gastric cancers 3Health News:Targeting leukemia cell's gene 'addiction' presents new strategy for treatment 2Health News:Soccer reduces risk of falls and bone fractures 2Health News:Soccer reduces risk of falls and bone fractures 3
... Scientifics SAFE-T-FILL Capillary Blood Collection Tubes are ... for a wide range of applications, the ... capillary tube, attached cap and a micro ... draw the blood into the micro tube ...
... RAM Scientifics SAFE-T-FILL Capillary Blood Collection ... systems. Available for a wide range of ... with a capillary tube, attached cap and ... action to draw the blood into the ...
... Blood Collection Tubes are 100% plastic capillary ... range of applications, the Capillary Collection Tubes ... cap and a micro tube.,The capillary tube ... into the micro tube thereby eliminating the ...
... test is an enzyme immunoassay test in a ... a 90-minute incubation. The results are objective ... results. The Bio-Rad Measles IgG test is ... human IgG antibodies to measles virus in human ...
Medicine Products: